756 results on '"Doherty, Mark"'
Search Results
2. Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor[FIGURE DASH]Resistant, EGFR–Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer
3. A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
4. Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland
5. Language deficits in primary lateral sclerosis: cortical atrophy, white matter degeneration and functional disconnection between cerebral regions
6. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
7. Brainstem–cortex disconnection in amyotrophic lateral sclerosis: bulbar impairment, genotype associations, asymptomatic changes and biomarker opportunities
8. Radiological correlates of pseudobulbar affect: Corticobulbar and cerebellar components in primary lateral sclerosis
9. Randomised, Phase II study of selumetinib, an oral inhibitor of MEK, in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer
10. Capturing the value of vaccination: impact of vaccine-preventable disease on hospitalization
11. Mapping cortical disease-burden at individual-level in frontotemporal dementia: implications for clinical care and pharmacological trials
12. Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD).
13. Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis
14. Infratentorial pathology in frontotemporal dementia: cerebellar grey and white matter alterations in FTD phenotypes
15. Extra-motor cerebral changes and manifestations in primary lateral sclerosis
16. Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancer
17. Amygdala pathology in amyotrophic lateral sclerosis and primary lateral sclerosis
18. Evolving diagnostic criteria in primary lateral sclerosis: The clinical and radiological basis of “probable PLS”
19. Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases
20. Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes
21. “Switchboard” malfunction in motor neuron diseases: Selective pathology of thalamic nuclei in amyotrophic lateral sclerosis and primary lateral sclerosis
22. Adjuvant treatment for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
23. A 3D Geological Fault Model for Characterisation of Geological Faults at the Proposed Site for the Wylfa Newydd Nuclear Power Plant, Wales
24. Vaccination as a preventative measure contributing to immune fitness
25. Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System
26. A framework for oral health care value-based payment approaches
27. Advanced Integrated Reticular Sorbent-Coated System to Capture CO2 from the Atmosphere (AIR2CO2)
28. C9orf72 Repeat Expansion Discordance in 6 Multigenerational Kindreds
29. Progressive Cerebrocerebellar Uncoupling in Sporadic and Genetic Forms of Amyotrophic Lateral Sclerosis.
30. Limbic Network and Papez Circuit Involvement in ALS: Imaging and Clinical Profiles in GGGGCC Hexanucleotide Carriers in C9orf72 and C9orf72 -Negative Patients.
31. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling
32. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study
33. The clinical and radiological profile of primary lateral sclerosis: a population-based study
34. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
35. Faculty Opinions recommendation of Characterizing infection of B cells with wild-type and vaccine strains of measles virus.
36. Language deficits in primary lateral sclerosis: cortical atrophy, white matter degeneration and functional disconnection between cerebral regions
37. The involvement of language‐associated networks, tracts, and cortical regions in frontotemporal dementia and amyotrophic lateral sclerosis: Structural and functional alterations
38. 296 a Population-Based Analysis of the Management of Symptoms of Depression Among Patients with Stage IV Non-Small Cell Lung Cancer in Ontario, Canada
39. The ESA Climate Change Initiative (CCI): A European contribution to the generation of the Global Climate Observing System
40. Prognostic and predictive effects of TP53 co-mutation in patients with EGFR-mutated non-small cell lung cancer (NSCLC)
41. Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy
42. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
43. Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancer
44. Enhancing Nutrition Support for Esophageal Cancer Patients: Understanding Factors Influencing Feeding Tube Utilization.
45. The solubility of low molecular weight Poly(Dimethyl siloxane) in dense CO2 and its use as a CO2-philic segment
46. Absence of thyroid transcription factor-1 expression is associated with poor survival in patients with advanced pulmonary adenocarcinoma treated with pemetrexed-based chemotherapy
47. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: a multimodal neuroimaging study
48. Faculty Opinions recommendation of The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis.
49. Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practice
50. A protocol for a systematic review with prospective individual patient data meta-analysis in EGFR mutant NSCLC with brain metastases to assess the effect of SRS + Osimertinib compared to Osimertinib alone: the STARLET collaboration
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.